The effect of regular and high doses of omeprazole on the intragastric acidity in patients with bleeding peptic ulcer treated endoscopically: A clinical trial with continuous intragastric pH monitoring

European Journal of Gastroenterology and Hepatology

Volumn 17, Issue 12, 2005, Pages 1351-1356

  Udd, Marianne ^a,c   Töyry, Jari ^b   Miettinen, Pekka ^b   Vanninen, Esko ^b   Mustonen, Harri ^c   Julkunen, Risto ^b  

^a Central Finland Central Hospital   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

24 h pH monitoring; Intragastric pH; Omeprazole; Peptic ulcer bleeding

Indexed keywords

OMEPRAZOLE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG DOSE REGIMEN; DRUG EFFECT; FEMALE; FIBRIN CLOT; GASTROINTESTINAL ENDOSCOPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER BLEEDING; PH MEASUREMENT; PRIORITY JOURNAL; STOMACH PH;

ADULT; AGED; ANTI-ULCER AGENTS; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GASTRIC ACIDITY DETERMINATION; HEMOSTASIS, ENDOSCOPIC; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; OMEPRAZOLE; PEPTIC ULCER HEMORRHAGE;

EID: 29244447088     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200512000-00014     Document Type: Article

References (29)

1. Green FW, Kaplan MM, Curtis LE, Levine PH. Effect of acid and pepsin on blood coagulation and platelet aggregation. Gastroenterology 1978; 74:38-43.
2. Patchett SE, O'Donoghue DP. Pharmacological manipulation of gastric juice: thromboelastographic assessment and implications for treatment of gastrointestinal haemorrhage. Gut 1995; 36:358-362.
3. Vreeburg EM, Levi M, Rauws EAJ, Deventer SJHV, Snel P, Bartelsman HWFM, et al. Enhanced mucosal fibrinolytic activity in gastroduodenal ulcer haemorrhage and beneficial effect of acid suppression. Aliment Pharmacol Ther 2001; 15:639-646.
4. Levine JE, Lentiadis GI, Sharma VK, Howden CW. Meta-analysis: the efficacy of intravenous H2-receptor antagonists in bleeding peptic ulcer. Aliment Pharmacol Ther 2002; 16:1137-1142.
5. Schaffalitzsky de Muckadell OB, Havelund T, Harling H, Boesby S, Snel P, Vreeburg EM, et al. Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre study. Scand J Gastroenterol 1997; 32:320-327.
6. Hasselgren G, Lind T, Lundell L, Aadland E, Efskind P, Falk A, et al. Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of placebo-controlled multicenter study. Scand J Gastroenterol 1997; 32:328-333.
7. Lau JYW, Sung JJY, Lee KKC, Yung M-Y, Wong SKH, Wu JCY, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 2000; 343:310-316.
8. Udd M, Miettinen P, Palmu A, Heikkinen M, Janatuinen E, Pasanen P, et al. Regular-dose versus high-dose omeprazole in peptic ulcer bleeding. A prospective randomised double-blind study. Scand J Gastroenterol 2001; 36:1332-1338.
9. Khuroo MS, Yattoo GN, Javid G, Khan BA, Shah AA, Gulzar GM, et al. A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med 1997; 336:1054-1058.
10. Javid G, Masoodi I, Zargar SA, Khan BA, Yatoo GN, Shah AH, et al. Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer. Am J Med 2001; 111: 280-284.
11. Kaviani MJ, Hashemi MR, Kazemifar AR, Roozitalab S, Mostaghni AA, Merat S, et al. Effect of oral omeprazole in reducing rebleeding in bleeding peptic ulcers: a prospective, double-blind, randomized, clinical trial. Aliment Pharmacol Ther 2003; 17:211-216.
12. Sung JJY, Chan FKL, Lau YW, Yung M-Y, Leung W-K, Wu JCY, et al. The effect of endoscopic therapy in patients receiving omeprazole for bleeding ulcers with nonbleeding visible vessels or adherent clots. Ann Intern Med 2003; 139:237-243.
13. Khuroo MS, Khuroo MS, Farahat KLC, Kagevi IE. Treatment with proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding: a meta-analysis. J Gastroenterol Hepatol 2005; 20:11-25.
14. Leonatidis GI, Sharma VK, Howden CW. Systematic review and metaanalysis of proton pump inhibitor therapy in peptic ulcer bleeding. Br Med J 2005; 330:568-575.
15. Rensburg CJ, Hartmann M, Thorpe A, Venter L, Theron I, Lühmann R, et al. Intragastric pH during continuous infusion with pantoprazole in patients with bleeding peptic ulcer. Am J Gastroenterol 2003; 98:2635-2641.
16. Singer JD, Willett JB. Applied longitudinal data-analysis - modelling change and event occurrence. New York: Oxford University Press; 2003.
17. Labenz J, Peitz U, Leusing C, Tillenburg B, Blum AL, Borsch G. Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study. Gut 1997; 40:36-41.
18. Lanas A, Artal A, Blás JM, Arroyo MT, Lopez-Zaborras J, Sáinz R. Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer. J Clin Gastroenterol 1995; 21:103-106.
19. Cederberg C, Röhss K, Lundborg P, Olbe L. Effect of once daily intravenous and oral omeprazole on 24 hour intragastric acidity in healthy subjects. Scand J Gastroenterol 1993; 28:179-184.
20. Teyssen S, Chari ST, Scheid J, Singer MV. Effect of repeated boluses of intravenous omeprazole and primed infusions of ranitidine on 24-hour intragastric pH in healthy human subjects. Dig Dis Sci 1995; 40:247-255.
21. Merki HS, Wilder-Smith CH. Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing? Gastroenterology 1994; 106:60-64.
22. Netzer P, Gaia C, Sandoz M, Huluk T, Gut A, Halter F, et al. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours. Am J Gastroenterol 1999; 94:351-357.
23. Lind T, Cederberg C, Idström J-P, Lönroth H, Olbe L, Lundell L. 24-hour intragastric acidity and plasma gastrin during long-term treatment with omeprazole or ranitidine in patients with reflux esophagitis. Scand J Gastroenterol 1991; 26:620-626.
24. Baak LC, Jensen JBM, Biemond I, Lamers CBHW. Weekend treatment with 20 mg and 40 mg omeprazole: effect on intragastric pH fasting, and postprandial serum gastrin, and serum pepsinogens. Gut 1991; 32:977-982.
25. Gillen D, Wirz AA, Neithercut WD, Ardill JES, McColl KEL. Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole. Gut 1999; 44:468-475.
26. Labenz J, Tillenburg B, Peitz U, Idström J-P, Verdú EF, Stolte M, et al. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 1996; 110:725-732.
27. Ishizaki T, Horai Y. Cytochrome P450 and the metabolism of proton pump inhibitors - emphasis on rabeprazole. Aliment Pharmacol Ther 1999; 13 (suppl 3):27-36.
28. Meyer UA. Metabolic interactions of the proton pump inhibitor lansoprazole, omeprazole and pantoprazole with other drugs. Eur J Gastroenterol Hepatol 1996; 8 (suppl 1):S21-S25.
29. Bertilsson L. Geographic/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP)2D6 and 2C19. Clin Pharmacokinet 1995; 29:192-209.